Company Profile

10x Genomics Stock Price, News & Analysis

Ticker:
TXG
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, 10x Genomics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Stock performance

31.87 USD (-3.25%)

Close

Last updated: June 23, 2026 at 00:00

4.05B USD

Market cap

Why the stock is moving

TXG is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

10x Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, 10x Genomics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Business Model Characteristics

10x Genomics is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.

Position Within the Biotechnology Landscape

Compared with therapeutic biotech names, 10x Genomics sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of 10x Genomics (TXG)?

    10x Genomics (TXG) most recently closed at 31.87 USD, a -3.25% move versus the previous session.

    What is the market cap of 10x Genomics (TXG)?

    10x Genomics currently has a market capitalization of 4.05B USD on BioPharmSignal.

    What does 10x Genomics do?

    10x Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    On which exchange is TXG stock listed?

    10x Genomics (TXG) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, 10x Genomics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles., Biotechnology.

    What is Genomics?

    10x Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    Which conditions is 10x Genomics targeting with Genomics?

    10x Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.